StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Diisopropylethylamine → (2R,3R)-4-(2-Chlorophenyl)-3-[4-ethyl-3-(6-methyl-2,4-dioxo-1,4-dihydro-2H-thieno[2,3-d]pyrimidin-3-yl)-benzoylamino]-2-hydroxy-butyric Acid

HRID 2361118
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 2361118
[N:1]([C:4]1[S:5][C:6]([CH3:13])=[CH:7][C:8]=1[C:9]([O:11]C)=O)=[C:2]=[O:3].[NH2:14][C:15]1[CH:16]=[C:17]([CH:21]=[CH:22][C:23]=1[CH2:24][CH3:25])[C:18]([OH:20])=O.CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C([O:61][C:62](=[O:75])[C@H:63]([OH:74])[C@H:64]([NH2:73])[CH2:65][C:66]1[CH:71]=[CH:70][CH:69]=[CH:68][C:67]=1[Cl:72])C>CN(C=O)C>[Cl:72][C:67]1[CH:68]=[CH:69][CH:70]=[CH:71][C:66]=1[CH2:65][C@@H:64]([NH:73][C:18](=[O:20])[C:17]1[CH:21]=[CH:22][C:23]([CH2:24][CH3:25])=[C:15]([N:14]2[C:9](=[O:11])[C:8]3[CH:7]=[C:6]([CH3:13])[S:5][C:4]=3[NH:1][C:2]2=[O:3])[CH:16]=1)[C@@H:63]([OH:74])[C:62]([OH:75])=[O:61]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 81531Diisopropylethylamine2×HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 124650433-Amino-4-ethylbenzoic acidHCID 20186671Methyl 2-isocyanato-5-methylthiophene-3-carboxylateHCID 71073615(2R,3R)-3-Amino-4-(2-chloro-phenyl)-2-hydroxy-butyric acid ethyl ester

Produkt 1

HCID 71073699(2R,3R)-4-(2-Chlorophenyl)-3-[4-ethyl-3-(6-methyl-2,4-dioxo-1,4-dihydro-2H-thieno[2,3-d]pyrimidin-3-yl)-benzoylamino]-2-hydroxy-butyric AcidAusbeute 100 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel3×

Reaktionsbedingungen

Temperatur
70 °C

Versuchsvorschrift

Methyl 2-isocyanato-5-methylthiophene-3-carboxylate (116 mg, 588 μmol, 1.5 eq.) was dissolved in DMF (1000 μL) then combined with 3-amino-4-ethyl-benzoic acid (64.8 mg, 392 μmol, 1.0 eq.) and DIPEA (137 μL, 2.0 eq.). The mixture was heated at 70° C. overnight. The solvent was removed and the product was combined with DMF (500 μL) and HATU (298 mg, 784 μmol, 2.0 eq.). The mixture was stirred at room temperature for 15 minutes before adding (2R,3R)-3-Amino-4-(2-chloro-phenyl)-2-hydroxy-butyric acid ethyl ester (TFA salt, 146 mg, 392 μmol, 1.0 eq.) in DIPEA (137 μL, 2.0 eq.) and DMF (500 μL). The mixture was stirred overnight at room temperature. The solvent was removed and the product was dissolved in THF (600 μL) and 2 M aqueous NaOH (600 μL). The mixture was heated at 80° C. overnight. The product was purified by preparative HPLC to yield the title compound (12.3 mg, 100% purity). MS m/z [M+H]+ calc'd for C26H24ClN3O6S, 542.11. found 542.0.

Aufarbeitung

  1. customThe solvent was removed
  2. stirringThe mixture was stirred overnight at room temperature
  3. customThe solvent was removed
  4. dissolutionthe product was dissolved in THF (600 μL)
  5. temperatureThe mixture was heated at 80° C. overnight
  6. customThe product was purified by preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-b1793f60c16f49a788706dc190be6699
Quelldatensatz
uspto-grants-2014_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08686184B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion